Year: 2006
Type: article
Abstract: Chronic obstructive pulmonary disease (COPD) is major public health problem worldwide induced by cigarette smoking.The pathogeneses of COPD is characterized by progressive difficulty in breathing and excessive mucus production.Previous studies have demonstrated that acrolein, a constituent of cigarette smoke increased mucin 5 (subtype A and C) (MUC5AC) production in the airways, however, the mechanism is unclear.The overall hypothesis of this dissertation is that acrolein increases MUC5AC production through activation of matrix metalloproteinases (MMPs).In airway epithelial cells, acrolein increased MUC5AC transcripts independent of oxidative stress, via a ligand-dependent, epidermal growth factor receptor (EGFR) and mitogen activated protein kinase (MAPK) activation.Acrolein increased MMP9 and MMP14 activity in vitro and in vivo.Small interfering (si) RNA to MMP9, MMP14 and a disintegrin and metalloproteinase domain protein (ADAM) 17 inhibited the acrolein-induced increase in MUC5AC transcripts in vitro.Acrolein-induced increase in MUC5AC transcripts and protein was lower in gene-targeted MMP9 mice (Mmp9 (-/-) ) than in Mmp9 (+/+) mice.Acrolein increased MMP9 and MMP14 transcripts via an EGFR-MAPK dependent mechanism and decreased the transcript level of tissue inhibitor of metalloproteinase protein (TIMP) 3, an endogenous inhibitor of ADAM17, MMP9 and MMP14 in vitro and in vivo.Thus, acrolein activates MMP9 to increase MUC5AC transcripts and protein via an initial EGFR ligand dependent mechanism.Chronic exposure to acrolein increases the protein levels and activity of MMP9 and MMP14, and decreases the transcript level of TIMP3 to initiate a positive feedback loop leading to persistent MUC5AC production.
Author: Hitesh Deshmukh
Institution: University of Cincinnati
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2508010937
